Oral administration of the antiobesity drugs, sibutramine and rimonabant, increases acetylcholine efflux selectively in the medial prefrontal cortex of the rat

Molecular Psychiatry

Volumn 13, Issue 3, 2008, Pages 240-241

  Davis, R J ^a,b   Nomikos, G G ^a,b  

^a ELI LILLY AND COMPANY   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANTIOBESITY AGENT; ATOMOXETINE; RIMONABANT; SIBUTRAMINE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; LETTER; MALE; NEUROCHEMISTRY; NEUROPSYCHIATRY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; APPETITE DEPRESSANTS; CYCLOBUTANES; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; PIPERIDINES; PREFRONTAL CORTEX; PYRAZOLES; RATS; RATS, WISTAR;

EID: 39449126445     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/sj.mp.4002112     Document Type: Letter

References (10)

1. Petrovich GD, Ross CA, Holland PC, Gallagher M. J Neurosci 2007; 27: 6436-6441.
2. Tataranni PA, Gautier J-F, Chen K, Uecker A, Bandy D, Salbe AD et al. Proc Natt Acad Sci USA 1999; 96: 4569-4574.
3. Everitt BJ, Robbins TW. Annu Rev Psychol 1997; 48: 649-684.
4. Tzavara ET, Bymaster FP, Overshiner CD, Davis RJ, Perry KW, Wolff M et al. Mol Psychiatry 2006; 11: 187-195.
5. Bazar KA, Yun AJ, Lee PY, Daniel SM, Doux JD. Med Hypotheses 2006; 66: 263-269.
6. Alonso-Alonso M, Pascual-Leone A. JAMA 2007; 297: 1819-1822.
7. Hofbauer KG, Nicholson JR, Boss O. Annu Rev Pharmacol Toxicol 2007; 47: 565-592.
8. Tzavara ET, Davis RJ, Perry KW, Li X, Salhoff C, Bymaster FP et al. Br J Pharmacol 2003; 138: 544-553.
9. Degroot A, Kofalvi A, Wade MR, Davis RJ, Rodrigues RJ, Rebola N et al. Mol Pharmacol 2006; 70: 1236-1245.
10. Gundlah C, Martin KF, Heal DJ, Auerbach SB. J Pharmacol Exp Ther 1997; 283: 581-591.